Abstract:microRNA-182-5p (miR-182-5p) has been shown to be associated with tumorigenesis in various types of human cancers. However, the clinical significance and roles of miR-182-5p in lung cancer have not been illustrated. The aim of this study was to assess the effects of miR-182-5p in lung cancer and its potential relevance to clinicopathological characteristics and survival. Here, we found that miR-182-5p was markedly upregulatedin lung cancer tissues and cell lines compared with adjacent non-tumor tissues and normal bronchial epithelial cell. The high expression of miR-182-5p was found to be significantly associated with lymph nodes metastasis. The lung cancer patients with high miR-182-5 p expression had a notably shorter overall survival than those with low miR-182-5 p expression. Furthermore, multivariate cox proportional hazards model showed that expression of miR-182-5 p was independent prognostic factors for overall survival of patients with lung cancer. In addition, by 3-(4,5-dimethylthi-azol-2-yl)- 2,5-diphenyltetrazolium bromide (MTT) and wound scratch assays, we found that knock-down of miR-182-5p resulted in retarded cell proliferation and migration in lung cancer. In summary, our findings indicate that miR-182-5p silencing suppresses the growth and migration of lung cancer and its up-regulation expression is associated with unfavorable prognosis, suggesting that miR-182-5p may be a promising biomarker for further risk stratification in the treatment of this cancer.

Supplementary Figure 2 from Mir-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation

Supplementary Methods, Figure Legends, Tables 1 - 2 from Mir-186 Downregulation Correlates with Poor Survival in Lung Adenocarcinoma, Where It Interferes with Cell-Cycle Regulation

Supplementary Figure 2 from Mir-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non–Small Cell Lung Cancer

Supplementary Figure 1 from Mir-205 Targets PTEN and PHLPP2 to Augment AKT Signaling and Drive Malignant Phenotypes in Non–Small Cell Lung Cancer

Supplementary Figure 1 from DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Downregulation of Mir-138 Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma.

Supplementary Figure 1 from Mir200c Attenuates P-gp–Mediated MDR and Metastasis by Targeting JNK2/c-Jun Signaling Pathway in Colorectal Cancer

Supplementary Figure 5 from DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Supplementary Figure 1 from Downregulation of Mir-138 Sustains NF-κB Activation and Promotes Lipid Raft Formation in Esophageal Squamous Cell Carcinoma

Supplementary Figure S1-S9 from Silencing of Long Noncoding RNA MIR22HG Triggers Cell Survival/Death Signaling Via Oncogenes YBX1, MET, and P21 in Lung Cancer

Reduced Mir-105-1 Levels Are Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer.

Supplementary Figure 4 from DNA Methylation-Mediated Repression of Mir-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer

Up-Regulation Of Mir-182-5p Predicts Poor Prognosis In Patients With Lung Cancer And Associates With Tumor Cell Growth And Migration

Down-Regulation of Mir-4500 Promoted Non-Small Cell Lung Cancer Growth

Supplementary Table 4 from AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial–Mesenchymal Transition and Suppresses Tumor Growth and Progression

Supplementary Figure 3 from Downregulation of Mir-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas

Supplementary Table 2 from A Regulatory Loop Involving Mir-22, Sp1, and C-Myc Modulates CD147 Expression in Breast Cancer Invasion and Metastasis

Supplementary Figure 4 from Downregulation of Mir-452 Promotes Stem-Like Traits and Tumorigenicity of Gliomas

Down-Regulation of Mir-452 is Associated with Poor Prognosis in the Non-Small-Cell Lung Cancer

Supplementary Figure 3 from A Sequence Polymorphism in <i>miR-608</i> Predicts Recurrence after Radiotherapy for Nasopharyngeal Carcinoma

Supplementary Figure from MiR-335 Inhibits Small Cell Lung Cancer Bone Metastases Via IGF-IR and RANKL Pathways